| Dozent/in |
Dr. Nicolas Schreiner |
| Veranstaltungsart |
Seminar |
| Code |
FS261114 |
| Semester |
Frühjahrssemester 2026 |
| Durchführender Fachbereich |
Wirtschaftswissenschaften |
| Studienstufe |
Master |
| Termin/e |
Di, 17.02.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 24.02.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 03.03.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 10.03.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 17.03.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 24.03.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 31.03.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 14.04.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 21.04.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 28.04.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 05.05.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 12.05.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 19.05.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220
Di, 26.05.2026, 16:15 - 18:00 Uhr, Inseliquai 10 INE 220 |
| Umfang |
2 Semesterwochenstunden |
| Turnus |
Weekly |
| Inhalt |
The aim of the course is to provide students with a robust understanding of specific issues in the market for pharmaceuticals. Students will be asked to read and summarize empirical research in order to answer real policy questions (problem-based learning). The topics covered in the course include pricing and price regulation, generic drugs, and the promotion of pharmaceuticals. |
| Lernziele |
The students are able to
(a) effectively read, summarize, present, and discuss empirical research,
(b) critically assess caveats in empirical papers
(c) derive questions for future research |
| Voraussetzungen |
Bachelor’s degree. The students are expected to have a good knowledge of microeconomics and econometrics. The prior attendance of the lecture “The Economics of Pharmaceutical Markets” is an asset, but not a strict requirement (if there are too many students who would like to participate, priority will be given to students who successfully attended the lecture). |
| Sprache |
Englisch |
| Begrenzung |
Max. 12 participants
If the maximum number of participants is reached, students of the MA in Economics and Management will be given priority. In this case, please contact wf@unilu.ch |
| Anmeldung |
Binding registration takes place via the UniPortal; see notes below in the «Proof of Performance» field.
For course information and materials, registration on the OLAT e-learning platform is required from 2 – 15 February 2026. The students themselves are responsible for verifying the course’s creditability towards their degree program.
Direct link to the OLAT course: to follow
|
| Leistungsnachweis |
***IMPORTANT*** In order to acquire credits, and/or take the examination, registration via the Uni Portal between 2 - 15 February 2026 is MANDATORY. Further information on registration: www.unilu.ch/wf/pruefungen |
| Abschlussform / Credits |
Individual/group presentation / 6 Credits
|
| Hinweise |
There will be six lectures during a preparation phase (from February 17 to March 31) and six dates for the presentations (from April 14 to May 19). Students will have to submit their final report before May 27, 11.59 p.m. |
| Hörer-/innen |
Nein |
| Kontakt |
nicolas.schreiner@doz.unilu.ch
nicolas.schreiner@css-institut.ch |
| Anzahl Anmeldungen |
0 von maximal 12 |
| Literatur |
Bhattacharya, Jay, Timothy Hyde and Peter Tu (2014), Health Economics, Palgrave Macmillan, New York. (Chapters 8, 12 – 14)
Danzon, Patricia M. and Sean Nicholson (eds.) (2012), The Oxford Handbook of the Economics of the Biopharmaceutical Industry, Oxford University Press, New York
Additional literature (e.g. the papers for the presentations) will be provided on OLAT. |